https://news.medxy.ai/zh/hope4abi-sexual-health/Medxy AIzh2026-10-31T06:04:24-07:00HOPE4ABI 数字化干预的可行性与影响：改善卒中及脑损伤后心理与性健康 https://news.medxy.ai/ja/hope4abi-digital-intervention/Medxy AIja2026-10-31T06:04:00-07:00HOPE4ABIの実現可能性と臨床的意義：脳卒中・脳損傷後の心と性のウェルビーイングを支えるデジタル介入 https://news.medxy.ai/vi/hope4abi-intervention-feasibility/Medxy AIvi2026-10-31T06:03:33-07:00HOPE4ABI: Can thiệp số hỗ trợ sức khỏe tinh thần và tình dục sau đột quỵ, tổn thương não có khả thi và hứa hẹn đến đâu? https://news.medxy.ai/feasibility-and-impact-of-hope4abi-a-digital-intervention-enhancing-mental-and-sexual-wellbeing-post-stroke-and-brain-injury/Medxy AIen2026-10-31T06:03:09-07:00Feasibility and Impact of HOPE4ABI: A Digital Intervention Enhancing Mental and Sexual Wellbeing Post-Stroke and Brain Injury https://news.medxy.ai/zh/cost-effectiveness-of-nonsurgical-periodontal-therapy/Medxy AIzh2026-10-31T06:02:30-07:00一般牙科实践中非手术牙周治疗的成本效益比较 https://news.medxy.ai/ja/cost-effectiveness-in-nonsurgical-periodontal-therapy/Medxy AIja2026-10-31T06:02:07-07:00一般歯科診療における非外科的歯周治療の費用対効果の比較 https://news.medxy.ai/vi/cost-effectiveness-of-nonsurgical-periodontal-therapy-2/Medxy AIvi2026-10-31T06:01:43-07:00So sánh hiệu quả chi phí của các liệu pháp nha chu không phẫu thuật trong thực hành tổng quát https://news.medxy.ai/comparative-cost-effectiveness-of-non-surgical-periodontal-therapies-in-general-practice/Medxy AIen2026-10-31T06:01:20-07:00Comparative Cost-Effectiveness of Non-Surgical Periodontal Therapies in General Practice https://news.medxy.ai/zh/refractory-colorectal-cancer-treatment/Medxy AIzh2026-10-31T06:00:41-07:00难治性转移性结直肠癌简化14天曲氟尿苷-替吡嘧啶联合贝伐珠单抗方案的非劣效性：PRABITAS试验解读 https://news.medxy.ai/ja/prabitas-trial-colorectal-cancer/Medxy AIja2026-10-31T06:00:12-07:00難治性転移性大腸がんに対するトリフルリジン・チピラシル＋ベバシズマブ14日間簡略レジメンの非劣性：PRABITAS試験からの知見 https://news.medxy.ai/vi/14-day-trifluridine-tipiracil-bevacizumab-regimen/Medxy AIvi2026-10-31T05:59:39-07:00Phác đồ 14 ngày trifluridine-tipiracil + bevacizumab: hiệu quả không kém hơn và ít độc tính hơn trong ung thư đại trực tràng di căn kháng trị https://news.medxy.ai/non-inferiority-of-a-simplified-14-day-trifluridine-tipiracil-plus-bevacizumab-regimen-for-refractory-metastatic-colorectal-cancer-insights-from-the-prabitas-trial/Medxy AIen2026-10-31T05:59:14-07:00Non-Inferiority of a Simplified 14-Day Trifluridine-Tipiracil plus Bevacizumab Regimen for Refractory Metastatic Colorectal Cancer: Insights from the PRABITAS Trial https://news.medxy.ai/ja/immunogenicity-and-safety/Medxy AIja2026-10-31T05:58:36-07:00思春期者におけるPHH-1V COVID-19ワクチンの異種ブースターとしての免疫原性と安全性 https://news.medxy.ai/vi/phh-1v-booster-adolescents/Medxy AIvi2026-10-31T05:58:09-07:00PHH-1V: Liều nhắc lại dị loại an toàn và sinh miễn dịch mạnh ở thanh thiếu niên https://news.medxy.ai/immunogenicity-and-safety-of-phh-1v-covid-19-vaccine-as-a-heterologous-booster-in-adolescents/Medxy AIen2026-10-31T05:57:48-07:00Immunogenicity and Safety of PHH-1V COVID-19 Vaccine as a Heterologous Booster in Adolescents https://news.medxy.ai/zh/immune-changes-before-arthritis/Medxy AIzh2026-10-31T05:57:14-07:00解码即将发病的类风湿关节炎中临床滑膜炎前的免疫学变化 https://news.medxy.ai/ja/immune-changes-before-rheumatoid-arthritis/Medxy AIja2026-10-31T05:56:50-07:00発症直前の関節リウマチにおける臨床滑膜炎前の免疫変化を読み解く https://news.medxy.ai/vi/preclinical-rheumatoid-arthritis/Medxy AIvi2026-10-31T05:56:23-07:00Giải mã những biến đổi miễn dịch trước khi viêm màng hoạt dịch lâm sàng xuất hiện trong viêm khớp dạng thấp sắp khởi phát https://news.medxy.ai/decoding-immunological-changes-preceding-clinical-synovitis-in-imminent-rheumatoid-arthritis/Medxy AIen2026-10-31T05:55:58-07:00Decoding Immunological Changes Preceding Clinical Synovitis in Imminent Rheumatoid Arthritis https://news.medxy.ai/zh/low-cost-organ-preservation/Medxy AIzh2026-10-31T05:55:20-07:00器官保存迎来新突破：超低成本开源常温体外灌注平台 https://news.medxy.ai/ja/low-cost-organ-preservation-2/Medxy AIja2026-10-31T05:54:59-07:00超低コスト・オープンソースで切り拓く臓器保存：常温体外灌流プラットフォームの革新 https://news.medxy.ai/vi/breakthrough-organ-preservation/Medxy AIvi2026-10-31T05:54:38-07:00Đột phá trong bảo tồn cơ quan: Nền tảng tưới máu ngoài cơ thể ở nhiệt độ sinh lý mã nguồn mở, chi phí siêu thấp https://news.medxy.ai/revolutionizing-organ-preservation-an-ultra-low-cost-open-source-normothermic-ex-vivo-perfusion-platform/Medxy AIen2026-10-31T05:54:17-07:00Revolutionizing Organ Preservation: An Ultra-low-cost, Open-source Normothermic Ex Vivo Perfusion Platform https://news.medxy.ai/zh/pediatric-lupus-progression-risk/Medxy AIzh2026-10-31T05:53:42-07:00儿童盘状红斑狼疮进展为系统性红斑狼疮的风险：来自多中心队列研究的启示 https://news.medxy.ai/ja/pediatric-lupus-progression-risk-3/Medxy AIja2026-10-31T05:53:16-07:00小児円板状エリテマトーデスが全身性エリテマトーデスへ進展するリスク：多施設コホート研究からの示唆 https://news.medxy.ai/vi/pediatric-lupus-progression/Medxy AIvi2026-10-31T05:52:46-07:00Nguy cơ tiến triển từ ban đỏ dạng đĩa ở trẻ em sang lupus ban đỏ hệ thống: Những phát hiện từ một nghiên cứu đoàn hệ đa trung tâm https://news.medxy.ai/risk-of-progression-from-pediatric-discoid-lupus-erythematosus-to-systemic-lupus-erythematosus-insights-from-a-multicenter-cohort-study/Medxy AIen2026-10-31T05:52:22-07:00Risk of Progression from Pediatric Discoid Lupus Erythematosus to Systemic Lupus Erythematosus: Insights from a Multicenter Cohort Study https://news.medxy.ai/zh/upper-eyelid-surgery-insights/Medxy AIzh2026-10-31T05:51:42-07:00上睑手术新视角：来自显微解剖研究的启示 https://news.medxy.ai/ja/microscopic-upper-eyelid-anatomy/Medxy AIja2026-10-31T05:51:20-07:00顕微鏡で見直す上眼瞼解剖：上眼瞼形成術の精度を高める新知見 https://news.medxy.ai/vi/upper-eyelid-anatomy-insights/Medxy AIvi2026-10-31T05:50:52-07:00Tạo hình mí trên dưới góc nhìn mới: những hiểu biết từ nghiên cứu giải phẫu vi thể https://news.medxy.ai/revolutionizing-upper-eyelid-surgery-insights-from-microscopic-anatomical-studies/Medxy AIen2026-10-31T05:50:31-07:00Revolutionizing Upper Eyelid Surgery: Insights from Microscopic Anatomical Studies https://news.medxy.ai/zh/multimodal-depression-relapse-prediction/Medxy AIzh2026-10-31T05:49:57-07:00多模态机器学习预测重性抑郁障碍复发：现有证据与未来方向 https://news.medxy.ai/ja/multimodal-for-depression-relapse-prediction/Medxy AIja2026-10-31T05:49:31-07:00マルチモーダル機械学習による大うつ病性障害の再発予測：既存のエビデンスと今後の展望 https://news.medxy.ai/vi/predicting-depression-relapse/Medxy AIvi2026-10-31T05:48:59-07:00Dự đoán tái phát trong rối loạn trầm cảm chủ yếu bằng học máy đa mô thức: Bằng chứng hiện nay và định hướng tương lai https://news.medxy.ai/multimodal-machine-learning-based-prediction-of-relapse-in-major-depressive-disorder-current-evidence-and-future-directions/Medxy AIen2026-10-31T05:48:34-07:00Multimodal Machine Learning-Based Prediction of Relapse in Major Depressive Disorder: Current Evidence and Future Directions https://news.medxy.ai/zh/machine-learning-ards-prediction/Medxy AIzh2026-10-31T05:47:50-07:00机器学习赋能胸片识别ARDS：可独立预测机械通气患者结局 https://news.medxy.ai/ja/ai-ards-detection/Medxy AIja2026-10-31T05:47:28-07:00AIで胸部X線を解析したARDS検出は、人工呼吸管理中患者の転帰予測を高める https://news.medxy.ai/vi/machine-learning-ards-prediction-2/Medxy AIvi2026-10-31T05:47:03-07:00Phát hiện ARDS trên phim X-quang bằng Machine Learning giúp dự báo kết cục ở bệnh nhân thở máy https://news.medxy.ai/machine-learning-enhanced-radiographic-detection-of-ards-predicts-outcomes-in-mechanically-ventilated-patients/Medxy AIen2026-10-31T05:46:39-07:00Machine Learning-Enhanced Radiographic Detection of ARDS Predicts Outcomes in Mechanically Ventilated Patients https://news.medxy.ai/zh/sustaining-insomnia-care/Medxy AIzh2026-10-31T05:45:58-07:00VA 初级保健心理健康门诊失眠照护如何实现持续：撤除实施支持对治疗提供与用药的影响 https://news.medxy.ai/ja/behavioral-insomnia-care-sustainability/Medxy AIja2026-10-31T05:45:33-07:00VAのPCMHIクリニックにおける行動的不眠ケアの持続：実装支援中止が治療提供と薬剤使用に及ぼす影響 https://news.medxy.ai/vi/maintaining-insomnia-care/Medxy AIvi2026-10-31T05:45:10-07:00Duy trì chăm sóc mất ngủ bằng liệu pháp hành vi tại các phòng khám PCMHI của VA: Tác động của việc rút chiến lược triển khai lên cung cấp điều trị và sử dụng thuốc https://news.medxy.ai/sustaining-behavioral-insomnia-care-in-va-pcmhi-clinics-impact-of-implementation-strategy-withdrawal-on-treatment-delivery-and-medication-use/Medxy AIen2026-10-31T05:44:48-07:00Sustaining Behavioral Insomnia Care in VA PCMHI Clinics: Impact of Implementation Strategy Withdrawal on Treatment Delivery and Medication Use https://news.medxy.ai/zh/relieving-t-cell-exhaustion/Medxy AIzh2026-10-31T05:44:14-07:00缓解 CD8 T 细胞耗竭：克服大 B 细胞淋巴瘤中 CAR T 细胞治疗失败的新策略 https://news.medxy.ai/ja/overcoming-car-t-cell-therapy-failure/Medxy AIja2026-10-31T05:43:47-07:00CD8陽性T細胞疲弊を標的に、CAR T細胞療法不成功を克服する：大細胞型B細胞リンパ腫における新たな戦略 https://news.medxy.ai/vi/reduce-cd8-t-cell-exhaustion/Medxy AIvi2026-10-31T05:43:18-07:00Giảm kiệt quệ tế bào T CD8 để khắc phục thất bại của liệu pháp CAR T-cell trong u lympho tế bào B lớn https://news.medxy.ai/mitigating-cd8-t-cell-exhaustion-to-overcome-car-t-cell-therapy-failure-in-large-b-cell-lymphoma/Medxy AIen2026-10-31T05:42:50-07:00Mitigating CD8 T-cell Exhaustion to Overcome CAR T-cell Therapy Failure in Large B-cell Lymphoma https://news.medxy.ai/zh/interstitial-lung-disease-diagnosis/Medxy AIzh2026-10-31T05:42:15-07:00提升间质性肺疾病诊断：支气管内光学相干断层成像在多学科评估中的作用 https://news.medxy.ai/ja/bronchial-optical-coherence-tomography/Medxy AIja2026-10-31T05:41:48-07:00間質性肺疾患診断を高める新たな視点：多職種評価における気管支内光干渉断層撮影の役割 https://news.medxy.ai/vi/interstitial-lung-disease-diagnosis-2/Medxy AIvi2026-10-31T05:41:18-07:00Nâng cao chẩn đoán bệnh phổi kẽ: Vai trò của chụp cắt lớp kết hợp quang học qua nội phế quản trong đánh giá đa chuyên khoa https://news.medxy.ai/enhancing-interstitial-lung-disease-diagnosis-the-role-of-endobronchial-optical-coherence-tomography-in-multidisciplinary-evaluation/Medxy AIen2026-10-31T05:40:52-07:00Enhancing Interstitial Lung Disease Diagnosis: The Role of Endobronchial Optical Coherence Tomography in Multidisciplinary Evaluation https://news.medxy.ai/zh/ophthalmology-residency-clinic-reform/Medxy AIzh2026-10-31T05:40:15-07:00重塑眼科住院医师门诊：促进健康公平并提升住院医师手术经验 https://news.medxy.ai/ja/ophthalmology-residency-clinic-reform-2/Medxy AIja2026-10-31T05:39:52-07:00眼科レジデント外来の再構築：健康の公平性促進とレジデントの外科的経験の向上 https://news.medxy.ai/vi/reform-in-ophthalmology-residency-clinic/Medxy AIvi2026-10-31T05:39:26-07:00Tái định hình các phòng khám dành cho bác sĩ nội trú chuyên ngành nhãn khoa: Thúc đẩy công bằng y tế và nâng cao trải nghiệm phẫu thuật cho bác sĩ nội trú https://news.medxy.ai/transforming-resident-eye-clinics-enhancing-health-equity-and-resident-surgical-experience/Medxy AIen2026-10-31T05:39:01-07:00Transforming Resident Eye Clinics: Enhancing Health Equity and Resident Surgical Experience https://news.medxy.ai/zh/tonsil-video-assessment-sleep-disorders/Medxy AIzh2026-10-31T05:38:23-07:00儿童睡眠呼吸障碍的扁桃体视频评估：进展、挑战与临床意义 https://news.medxy.ai/ja/video-based-tonsil-assessment/Medxy AIja2026-10-31T05:37:56-07:00小児の睡眠呼吸障害における扁桃サイズ評価を動画で行う新手法：進展、課題、臨床的意義 https://news.medxy.ai/vi/tonsil-size-assessment/Medxy AIvi2026-10-31T05:37:24-07:00Đánh giá kích thước amidan ở trẻ rối loạn hô hấp khi ngủ bằng video: tiến bộ, thách thức và ý nghĩa lâm sàng https://news.medxy.ai/video-based-assessment-of-tonsil-size-in-children-with-sleep-disordered-breathing-advances-challenges-and-clinical-implications/Medxy AIen2026-10-31T05:36:56-07:00Video-Based Assessment of Tonsil Size in Children With Sleep-Disordered Breathing: Advances, Challenges, and Clinical Implications https://news.medxy.ai/zh/pancreatic-vein-resection-study/Medxy AIzh2026-10-31T05:36:10-07:00胰腺癌手术中门静脉肠系膜静脉切除：切线性与节段性方式的全球队列研究新发现 https://news.medxy.ai/ja/pancreatic-vein-resection-study-2/Medxy AIja2026-10-31T05:35:43-07:00膵がん手術における門静脈・腸間膜静脈切除：切線切除と区域切除に関する国際コホート研究の新たな知見 https://news.medxy.ai/vi/portal-mesenteric-resection-techniques/Medxy AIvi2026-10-31T05:35:16-07:00Cắt tĩnh mạch cửa–mạc treo tràng trên tiếp tuyến hay cắt đoạn trong phẫu thuật ung thư tụy: Kết luận từ một nghiên cứu đoàn hệ toàn cầu https://news.medxy.ai/tangential-versus-segmental-portomesenteric-venous-resection-in-pancreatic-cancer-surgery-insights-from-a-global-cohort-study/Medxy AIen2026-10-31T05:34:51-07:00Tangential Versus Segmental Portomesenteric Venous Resection in Pancreatic Cancer Surgery: Insights from a Global Cohort Study https://news.medxy.ai/zh/meningioma-risk-assessment/Medxy AIzh2026-10-31T05:34:14-07:00雌孕激素与单孕激素治疗使用者的脑膜瘤风险评估：来自 EudraVigilance 药物警戒数据的启示 https://news.medxy.ai/ja/meningioma-risk-assessment-2/Medxy AIja2026-10-31T05:33:48-07:00エストロゲン・プロゲスチン製剤とプロゲスチン単剤療法における髄膜腫リスク評価：EudraVigilance ファーマコビジランスデータからの知見 https://news.medxy.ai/vi/meningioma-risk-hormone-therapy/Medxy AIvi2026-10-31T05:33:19-07:00Đánh giá nguy cơ u màng não ở người dùng liệu pháp estro-progestin và progestin đơn độc: Góc nhìn từ dữ liệu cảnh giác dược EudraVigilance https://news.medxy.ai/evaluating-meningioma-risk-in-users-of-estro-progestin-and-progestin-only-therapies-insights-from-eudravigilance-pharmacovigilance-data/Medxy AIen2026-10-31T05:32:54-07:00Evaluating Meningioma Risk in Users of Estro-Progestin and Progestin-only Therapies: Insights from EudraVigilance Pharmacovigilance Data https://news.medxy.ai/zh/targeting-mevalonate-biosynthesis/Medxy AIzh2026-10-31T05:32:15-07:00靶向甲羟戊酸生物合成：对抗吉西他滨耐药性胰腺癌的新策略 https://news.medxy.ai/ja/gemcitabine-resistant-pancreatic-cancer/Medxy AIja2026-10-31T05:31:51-07:00ゲムシタビン耐性膵癌を狙う新戦略：メバロン酸生合成経路への着目 https://news.medxy.ai/vi/targeting-mevalonate-biosynthesis-2/Medxy AIvi2026-10-31T05:31:24-07:00Nhắm vào sinh tổng hợp mevalonate: chiến lược mới chống ung thư tụy kháng gemcitabine https://news.medxy.ai/targeting-mevalonate-biosynthesis-a-novel-strategy-against-gemcitabine-resistant-pancreatic-cancer/Medxy AIen2026-10-31T05:31:03-07:00Targeting Mevalonate Biosynthesis: A Novel Strategy Against Gemcitabine-resistant Pancreatic Cancer https://news.medxy.ai/zh/blood-biomarkers-dementia-prediction/Medxy AIzh2026-10-31T05:30:25-07:00血液生物标志物能否用于痴呆长期预测？——Whitehall II 队列研究带来的启示 https://news.medxy.ai/ja/blood-biomarkers-predict-dementia/Medxy AIja2026-10-31T05:30:01-07:00血液バイオマーカーで認知症を長期予測できるか：Whitehall II コホートから得られた知見 https://news.medxy.ai/vi/blood-biomarkers-predict-dementia-whitehall-ii/Medxy AIvi2026-10-31T05:29:31-07:00Các dấu ấn sinh học trong máu có thể được sử dụng để dự đoán chứng sa sút trí tuệ trong dài hạn không? — Những thông tin từ nghiên cứu đoàn hệ Whitehall II https://news.medxy.ai/evaluating-blood-based-biomarkers-for-long-term-prediction-of-dementia-insights-from-the-whitehall-ii-cohort/Medxy AIen2026-10-31T05:29:08-07:00Evaluating Blood-Based Biomarkers for Long-Term Prediction of Dementia: Insights from the Whitehall II Cohort https://news.medxy.ai/zh/muscle-lipid-metabolism-disorders/Medxy AIzh2026-10-31T05:28:33-07:00男性性腺功能减退中的骨骼肌与脂质代谢紊乱：来自干预性代谢组学分析的启示 https://news.medxy.ai/ja/lipid-metabolism-hypogonadism-in-men/Medxy AIja2026-10-31T05:28:08-07:00男性性腺機能低下症における骨格筋および脂質代謝の異常：介入的メタボロミクス解析からの示唆 https://news.medxy.ai/vi/lipid-metabolism-hypogonadism-men/Medxy AIvi2026-10-31T05:27:40-07:00Rối loạn chuyển hóa lipid và cơ xương ở nam giới thiểu năng sinh dục: Góc nhìn từ phân tích metabolomic can thiệp https://news.medxy.ai/skeletal-muscle-and-lipid-metabolism-disruption-in-male-hypogonadism-insights-from-interventional-metabolomic-profiling/Medxy AIen2026-10-31T05:27:15-07:00Skeletal Muscle and Lipid Metabolism Disruption in Male Hypogonadism: Insights from Interventional Metabolomic Profiling https://news.medxy.ai/zh/smart-reach2-model/Medxy AIzh2026-10-31T05:26:37-07:00SMART-REACH2：用于预测终生心血管风险并优化已确诊动脉粥样硬化性心血管疾病预防治疗的全球模型 https://news.medxy.ai/ja/smart-reach2-risk-prediction-model/Medxy AIja2026-10-31T05:26:15-07:00SMART-REACH2：生涯にわたる心血管リスクを予測し、動脈硬化性心血管疾患と診断された患者に対する予防・治療を最適化するためのグローバルモデル https://news.medxy.ai/vi/smart-reach2-risk-model/Medxy AIvi2026-10-31T05:25:50-07:00SMART-REACH2: Một mô hình toàn cầu giúp dự đoán nguy cơ tim mạch suốt đời và tối ưu hóa điều trị dự phòng ở những bệnh nhân đã mắc bệnh tim mạch do xơ vữa https://news.medxy.ai/smart-reach2-a-global-model-for-predicting-lifetime-cardiovascular-risk-and-tailoring-preventive-therapy-in-established-atherosclerotic-disease/Medxy AIen2026-10-31T05:25:28-07:00SMART-REACH2: A Global Model for Predicting Lifetime Cardiovascular Risk and Tailoring Preventive Therapy in Established Atherosclerotic Disease https://news.medxy.ai/zh/revision-risk-graft-choice/Medxy AIzh2026-10-30T05:24:47-07:00足球运动员前交叉韧带重建翻修风险并不取决于移植物选择：瑞典全国队列研究新发现 https://news.medxy.ai/ja/revision-risk-graft-choice-acl/Medxy AIja2026-10-30T05:24:19-07:00Nguy cơ phải phẫu thuật lại sau khi tái tạo dây chằng chéo trước ở cầu thủ bóng đá không phụ thuộc vào loại mảnh ghép được sử dụng https://news.medxy.ai/vi/acl-graft-choice-revision-risk/Medxy AIvi2026-10-30T05:23:48-07:00Lựa chọn mảnh ghép không làm thay đổi nguy cơ tái tạo ACL lần sửa đổi ở cầu thủ bóng đá: dữ liệu từ một đoàn hệ toàn quốc của Thụy Điển https://news.medxy.ai/graft-choice-does-not-influence-revision-acl-reconstruction-risk-in-football-players-insights-from-a-swedish-nationwide-cohort/Medxy AIen2026-10-30T05:23:23-07:00Graft Choice Does Not Influence Revision ACL Reconstruction Risk in Football Players: Insights from a Swedish Nationwide Cohort https://news.medxy.ai/ja/poor-exercise-adherence/Medxy AIja2026-10-30T05:22:24-07:00多疾患併存患者における運動療法の参加不良：MOBILIZE試験から見えた実態 https://news.medxy.ai/vi/why-multimorbid-patients-miss-training/Medxy AIvi2026-10-30T05:21:58-07:00Vì sao bệnh nhân đa bệnh lý ít đến buổi tập luyện? Phân tích từ thử nghiệm MOBILIZE https://news.medxy.ai/zh/tmj-molecular-subtypes/Medxy AIzh2026-10-30T05:20:55-07:00揭示TMJ疾病的分子亚型：整合多组学解析非线性疾病进展 https://news.medxy.ai/ja/tmj-molecular-subtypes-2/Medxy AIja2026-10-30T05:20:32-07:00TMJ疾患の分子サブタイプを解明：統合マルチオミクス解析が示した非線形進行の新知見 https://news.medxy.ai/vi/tmj-molecular-subgroups/Medxy AIvi2026-10-30T05:20:04-07:00Khám phá các phân nhóm phân tử trong bệnh lý TMJ: phát hiện từ phân tích multi-omics tích hợp cho thấy diễn tiến bệnh phi tuyến tính https://news.medxy.ai/zh/sibeprenlimab-iga-nephropathy/Medxy AIzh2026-10-30T05:18:53-07:00Sibeprenlimab在IgA肾病中显示出肾功能保护作用：VISIONARYⅢ期试验最终结果解读 https://news.medxy.ai/ja/sibeprenlimab-iga-nephropathy-2/Medxy AIja2026-10-30T05:18:30-07:00IgA腎症で腎機能保護を示したシベプレンリマブ：第3相VISIONARY試験最終解析から見えたこと https://news.medxy.ai/vi/sibeprenlimab-for-iga-nephropathy/Medxy AIvi2026-10-30T05:18:05-07:00Sibeprenlimab cho thấy hiệu quả bảo vệ chức năng thận ở bệnh nhân bệnh thận IgA: Những thông tin từ phân tích cuối cùng của thử nghiệm giai đoạn 3 VISIONARY https://news.medxy.ai/sibeprenlimab-demonstrates-kidney-function-preservation-in-iga-nephropathy-insights-from-the-final-phase-3-visionary-trial/Medxy AIen2026-10-30T05:17:42-07:00Sibeprenlimab Demonstrates Kidney Function Preservation in IgA Nephropathy: Insights from the Final Phase 3 VISIONARY Trial https://news.medxy.ai/zh/oct-predicts-ms-progression/Medxy AIzh2026-10-30T03:21:08-07:00光学相干断层扫描能否预测多发性硬化进展？——美国眼科学会报告解读 https://news.medxy.ai/ja/oct-in-ms-prognosis/Medxy AIja2026-10-30T03:20:47-07:00多発性硬化症の予後予測における光干渉断層計：American Academy of Ophthalmology報告からの知見 https://news.medxy.ai/vi/optical-coherence-tomography-as-a-prognostic-biomarker-in-multiple-sclerosis/Medxy AIvi2026-10-30T03:20:23-07:00Chụp cắt lớp quang học (OCT) như một dấu ấn sinh học tiên lượng trong bệnh đa xơ cứng: Những thông tin từ báo cáo của Viện Hàn lâm Nhãn khoa Hoa Kỳ https://news.medxy.ai/optical-coherence-tomography-as-a-prognostic-biomarker-in-multiple-sclerosis-insights-from-the-american-academy-of-ophthalmology-report/Medxy AIen2026-10-30T03:20:02-07:00Optical Coherence Tomography as a Prognostic Biomarker in Multiple Sclerosis: Insights from the American Academy of Ophthalmology Report https://news.medxy.ai/zh/predicting-surgery-success-in-children/Medxy AIzh2026-10-30T03:19:23-07:00儿童阻塞性睡眠呼吸暂停手术成功率如何预测？——加权分析揭示扁桃体切除术结局的关键因素 https://news.medxy.ai/ja/predicting-surgical-success-in-pediatric-sleep-apnea/Medxy AIja2026-10-30T03:19:00-07:00小児閉塞性睡眠時無呼吸における手術成功をどう予測するか：扁桃摘出術成績の重み付け解析から見えたこと https://news.medxy.ai/vi/surgical-outcomes-sleep-apnea/Medxy AIvi2026-10-30T03:18:30-07:00Dự báo thành công phẫu thuật ở trẻ em mắc ngưng thở tắc nghẽn khi ngủ: Góc nhìn từ phân tích có trọng số về kết quả cắt amidan https://news.medxy.ai/predicting-surgical-success-in-pediatric-obstructive-sleep-apnea-insights-from-weighted-analysis-of-tonsillectomy-outcomes/Medxy AIen2026-10-30T03:18:07-07:00Predicting Surgical Success in Pediatric Obstructive Sleep Apnea: Insights from Weighted Analysis of Tonsillectomy Outcomes https://news.medxy.ai/zh/multimodal-robotic-surgery-prediction/Medxy AIzh2026-10-30T03:17:29-07:00机器人手术的多模态预测：任务层面运动学指标的附加价值评估 https://news.medxy.ai/ja/advancing-robotic-surgery-prediction/Medxy AIja2026-10-30T03:17:08-07:00ロボット手術予測の新展開：タスクレベル運動学指標の付加価値を検証する https://news.medxy.ai/vi/multimodal-prediction-in-robotic-surgery/Medxy AIvi2026-10-30T03:16:40-07:00Dự đoán đa phương thức trong phẫu thuật bằng robot: Đánh giá giá trị gia tăng của các chỉ số động học ở cấp độ thao tác https://news.medxy.ai/multimodal-prediction-in-robotic-surgery-evaluating-the-added-value-of-task-level-kinematic-metrics/Medxy AIen2026-10-30T03:16:17-07:00Multimodal Prediction in Robotic Surgery: Evaluating the Added Value of Task-Level Kinematic Metrics https://news.medxy.ai/zh/ivf-outperforms-surgery-in-endometriosis-infertility/Medxy AIzh2026-10-30T03:15:33-07:00IVF在深部及卵巢型子宫内膜异位症不孕治疗中优于手术：一项部分随机化患者偏好试验的新启示 https://news.medxy.ai/ja/ivf-outperforms-surgery-infertiiity/Medxy AIja2026-10-30T03:15:12-07:00深部・卵巣子宮内膜症による不妊ではIVFが手術を上回る：部分無作為化患者選好試験からの示唆 https://news.medxy.ai/vi/ivf-vs-surgery-endometriosis-infertility/Medxy AIvi2026-10-30T03:14:45-07:00IVF vượt trội hơn phẫu thuật trong vô sinh do lạc nội mạc tử cung sâu và buồng trứng: kết quả từ một thử nghiệm ngẫu nhiên hóa một phần theo ưu tiên của bệnh nhân https://news.medxy.ai/ivf-surpasses-surgery-for-infertility-in-deep-and-ovarian-endometriosis-insights-from-a-partially-randomized-patient-preference-trial/Medxy AIen2026-10-30T03:14:23-07:00IVF Surpasses Surgery for Infertility in Deep and Ovarian Endometriosis: Insights from a Partially Randomized Patient Preference Trial https://news.medxy.ai/zh/microbiome-taurine-axis-eel/Medxy AIzh2026-10-30T03:13:42-07:00解密“微生物群—牛磺酸”轴：海藻酸盐纤维如何促进结肠炎黏膜愈合 https://news.medxy.ai/ja/gut-microbiome-taurine-axis/Medxy AIja2026-10-30T03:13:16-07:00腸内細菌叢-タウリン軸の新機序を解明　アルギン酸食物繊維が大腸炎の粘膜修復を促進 https://news.medxy.ai/vi/unveiling-the-microbiota-taurine-axis-alginate-fibers/Medxy AIvi2026-10-30T03:12:44-07:00Khám phá trục hệ vi sinh vật – taurine: Vai trò của sợi alginate trong việc thúc đẩy quá trình chữa lành niêm mạc ở bệnh viêm đại tràng https://news.medxy.ai/unveiling-the-microbiota-taurine-axis-alginate-fibers-role-in-promoting-mucosal-healing-in-colitis/Medxy AIen2026-10-30T03:12:19-07:00Unveiling the Microbiota-Taurine Axis: Alginate Fiber’s Role in Promoting Mucosal Healing in Colitis https://news.medxy.ai/zh/inflammatory-bowel-disease-risk/Medxy AIzh2026-10-30T03:11:36-07:00抗 CD20 治疗后多发性硬化患者炎症性肠病风险升高：来自瑞典人群队列的研究 https://news.medxy.ai/ja/inflammatory-bowel-disease-risk-2/Medxy AIja2026-10-30T03:11:05-07:00抗CD20治療後に炎症性腸疾患リスクが上昇：スウェーデン全国コホートでみた多発性硬化症患者の実態 https://news.medxy.ai/vi/bowel-inflammation-risk/Medxy AIvi2026-10-30T03:10:35-07:00Nguy cơ bệnh viêm ruột tăng sau điều trị anti-CD20 ở bệnh nhân đa xơ cứng: Góc nhìn từ một đoàn hệ dựa trên dân số của Thụy Điển https://news.medxy.ai/elevated-risk-of-inflammatory-bowel-disease-following-anti-cd20-therapy-in-multiple-sclerosis-patients-insights-from-a-swedish-population-based-cohort/Medxy AIen2026-10-30T03:10:11-07:00Elevated Risk of Inflammatory Bowel Disease Following Anti-CD20 Therapy in Multiple Sclerosis Patients: Insights from a Swedish Population-Based Cohort https://news.medxy.ai/zh/menopause-hormone-therapy-safety/Medxy AIzh2026-10-30T03:09:24-07:00重新审视绝经激素治疗的安全性与临床意义：来自当代证据的解读 https://news.medxy.ai/ja/rethinking-menopause-hormone-therapy/Medxy AIja2026-10-30T03:09:04-07:00更年期ホルモン療法の安全性と臨床的意義を再考する：最新エビデンスからみた視点 https://news.medxy.ai/vi/menopause-hormone-therapy-safety-review/Medxy AIvi2026-10-30T03:08:38-07:00Tái đánh giá độ an toàn và ý nghĩa lâm sàng của liệu pháp hormone thời kỳ mãn kinh: Góc nhìn hiện đại https://news.medxy.ai/reevaluating-the-safety-and-clinical-implications-of-menopausal-hormone-therapy-a-contemporary-perspective/Medxy AIen2026-10-30T03:08:14-07:00Reevaluating the Safety and Clinical Implications of Menopausal Hormone Therapy: A Contemporary Perspective https://news.medxy.ai/zh/microplastics-heart-disease/Medxy AIzh2026-10-30T03:07:36-07:00冠状循环中的微塑料与纳米塑料：揭示其在缺血性心脏病及空气污染暴露中的作用 https://news.medxy.ai/ja/microplastics-coronary-circulation/Medxy AIja2026-10-30T03:07:13-07:00冠循環に潜むマイクロ・ナノプラスチック：虚血性心疾患と大気汚染曝露との関連を読み解く https://news.medxy.ai/vi/micro-nano-plastics-in-coronary-circulation-unveiling-their-role-in-ischemic-heart-disease-and-air-pollution-exposure/Medxy AIvi2026-10-30T03:06:49-07:00Vi nhựa và nano nhựa trong tuần hoàn mạch vành: Hé lộ vai trò của chúng đối với bệnh tim thiếu máu cục bộ và tình trạng phơi nhiễm ô nhiễm không khí https://news.medxy.ai/micro-and-nano-plastics-in-coronary-circulation-unveiling-their-role-in-ischemic-heart-disease-and-air-pollution-exposure/Medxy AIen2026-10-30T03:06:26-07:00Micro- and Nano-Plastics in Coronary Circulation: Unveiling Their Role in Ischemic Heart Disease and Air Pollution Exposure https://news.medxy.ai/zh/return-to-sport-after-acl-reconstruction/Medxy AIzh2026-10-30T03:05:42-07:00ACL重建后重返运动：来自瑞典全国高活动运动员队列的研究洞见 https://news.medxy.ai/ja/sports-return-after-acl-reconstruction/Medxy AIja2026-10-30T03:05:19-07:00ACL再建後のスポーツ復帰はどこまで可能か――スウェーデン全国コホートが示した高活動アスリートの実態 https://news.medxy.ai/vi/return-to-sport-after-acl-reconstruction-2/Medxy AIvi2026-10-30T03:04:48-07:00Quay lại thể thao sau tái tạo ACL: Góc nhìn từ một đoàn hệ vận động viên Thụy Điển có mức độ hoạt động cao https://news.medxy.ai/return-to-sport-after-acl-reconstruction-insights-from-a-nationwide-swedish-cohort-of-high-activity-athletes/Medxy AIen2026-10-30T03:04:26-07:00Return to Sport After ACL Reconstruction: Insights from a Nationwide Swedish Cohort of High-Activity Athletes https://news.medxy.ai/zh/quality-of-life-profiles/Medxy AIzh2026-10-30T03:03:46-07:00康复患者生活质量剖面的识别：来自潜在剖面分析的启示 https://news.medxy.ai/ja/cross-diagnostic-quality-of-life-profiles/Medxy AIja2026-10-30T03:03:22-07:00リハビリテーション患者の生活の質プロファイルを診断横断的に捉える：潜在プロファイル分析からの知見 https://news.medxy.ai/vi/quality-of-life-phenotypes/Medxy AIvi2026-10-30T03:02:52-07:00Phân loại các kiểu hình chất lượng cuộc sống ở bệnh nhân phục hồi chức năng: Góc nhìn từ phân tích kiểu hình tiềm ẩn https://news.medxy.ai/characterizing-quality-of-life-profiles-in-rehabilitation-patients-across-diagnoses-insights-from-latent-profile-analysis/Medxy AIen2026-10-30T03:02:29-07:00Characterizing Quality of Life Profiles in Rehabilitation Patients Across Diagnoses: Insights from Latent Profile Analysis https://news.medxy.ai/zh/pregnancy-chemical-exposure-teeth/Medxy AIzh2026-10-30T03:01:51-07:00妊娠期邻苯二甲酸酯与双酚A暴露：与儿童第二乳磨牙矿化不足的关联 https://news.medxy.ai/ja/prenatal-chemical-exposure-dental-defects/Medxy AIja2026-10-30T03:01:09-07:00妊娠中のフタル酸エステル類・ビスフェノールA曝露と子どもの第二乳臼歯低石灰化との関連 https://news.medxy.ai/vi/prenatal-chemical-exposure-tooth-enamel/Medxy AIvi2026-10-30T03:00:27-07:00Phơi nhiễm Phthalates và Bisphenol Trước Sinh Liên Quan Gì Đến Tình Trạng Giảm Khoáng Hóa Răng Cối Sữa Thứ Hai ở Trẻ Em? https://news.medxy.ai/prenatal-exposure-to-phthalates-and-bisphenols-and-its-association-with-hypomineralization-of-second-primary-molars-in-children/Medxy AIen2026-10-30T03:00:02-07:00Prenatal Exposure to Phthalates and Bisphenols and Its Association with Hypomineralization of Second Primary Molars in Children https://news.medxy.ai/zh/povetacicept-iga-nephropathy-3-trial/Medxy AIzh2026-10-30T02:59:16-07:00Povetacicept 在 IgA 肾病 3 期试验中显示出可喜的中期结果 https://news.medxy.ai/ja/povetacicept-trial-results/Medxy AIja2026-10-30T02:59:03-07:00IgA腎症の第3相試験でpovetaciceptが有望な中間結果を示す https://news.medxy.ai/vi/povetacicept-iga-trial/Medxy AIvi2026-10-30T02:58:37-07:00Povetacicept cho thấy kết quả tạm thời đầy hứa hẹn trong thử nghiệm pha 3 ở bệnh thận IgA https://news.medxy.ai/povetacicept-shows-promising-interim-results-in-phase-3-trial-for-iga-nephropathy/Medxy AIen2026-10-30T02:58:18-07:00Povetacicept Shows Promising Interim Results in Phase 3 Trial for IgA Nephropathy https://news.medxy.ai/zh/sirolimus-coated-balloon-angioplasty/Medxy AIzh2026-10-30T02:30:38-07:00西罗莫司涂层球囊血管成形术在无组织丧失的股腘动脉疾病中的应用：SirPAD试验的积极次要结局 https://news.medxy.ai/ja/promising-sirpad-results/Medxy AIja2026-10-30T02:30:17-07:00組織欠損を伴わない大腿膝窩動脈疾患に対するシロリムス被覆バルーン血管形成術：SirPAD試験二次解析で示された有望な成績 https://news.medxy.ai/vi/sirolimus-coated-balloon-angioplasty-2/Medxy AIvi2026-10-30T02:29:52-07:00Sử dụng bóng nong mạch phủ Sirolimus trong điều trị bệnh lý động mạch đùi-khoeo ở bệnh nhân không có tình trạng mất mô https://news.medxy.ai/sirolimus-coated-balloon-angioplasty-in-femoropopliteal-artery-disease-without-tissue-loss-promising-secondary-outcomes-from-the-sirpad-trial/Medxy AIen2026-10-30T02:29:32-07:00Sirolimus-Coated Balloon Angioplasty in Femoropopliteal Artery Disease Without Tissue Loss: Promising Secondary Outcomes from the SirPAD Trial https://news.medxy.ai/zh/rilvegostomig-trastuzumab-deruxtecan-breast-cancer-2/Medxy AIzh2026-10-30T02:28:57-07:00rilvegostomig 联合 trastuzumab-deruxtecan：早期 ERBB2 阴性乳腺癌的新辅助治疗新希望 https://news.medxy.ai/ja/rilvegostomig-trastuzumab-deruxtecan-neoadjuvant-therapy/Medxy AIja2026-10-30T02:28:35-07:00rilvegostomig＋trastuzumab-deruxtecan：ERBB2陰性早期乳癌に対する有望な術前療法 https://news.medxy.ai/vi/rilvegostomig-trastuzumab-deruxtecan-breast-cancer/Medxy AIvi2026-10-30T02:28:12-07:00Rilvegostomig phối hợp trastuzumab-deruxtecan: liệu pháp tân bổ trợ đầy hứa hẹn cho ung thư vú giai đoạn sớm ERBB2 âm tính https://news.medxy.ai/rilvegostomig-plus-trastuzumab-deruxtecan-a-promising-neoadjuvant-therapy-in-early-stage-erbb2-negative-breast-cancer/Medxy AIen2026-10-30T02:27:51-07:00Rilvegostomig Plus Trastuzumab-Deruxtecan: A Promising Neoadjuvant Therapy in Early-Stage ERBB2-Negative Breast Cancer https://news.medxy.ai/zh/acl-bundle-osteochondritis-correlation/Medxy AIzh2026-10-30T02:27:07-07:00前交叉韧带后外侧束位置与外侧股骨髁骨软骨剥离症的相关性：新的解剖学发现 https://news.medxy.ai/ja/association-of-posterolateral-acl-bundle-position-with-osteochondritis-dissecans-of-the-lateral-femoral-condyle/Medxy AIja2026-10-30T02:26:46-07:00前十字靭帯（ACL）後外側束の付着部位置と外側大腿骨顆の離断性骨軟骨炎との関連：新たな解剖学的視点 https://news.medxy.ai/vi/acl-posterolateral-bundle-dislocation/Medxy AIvi2026-10-30T02:26:25-07:00Mối liên quan giữa vị trí bó sau ngoài của ACL và osteochondritis dissecans ở lồi cầu đùi ngoài: một góc nhìn giải phẫu mới https://news.medxy.ai/association-of-posterolateral-acl-bundle-position-with-osteochondritis-dissecans-of-the-lateral-femoral-condyle-a-new-anatomical-insight/Medxy AIen2026-10-30T02:26:06-07:00Association of Posterolateral ACL Bundle Position with Osteochondritis Dissecans of the Lateral Femoral Condyle: A New Anatomical Insight https://news.medxy.ai/zh/bimodal-swallow-rehabilitation/Medxy AIzh2026-10-30T02:25:25-07:00双模态生物反馈助力卒中后吞咽康复：对声门上吞咽动作的改善作用 https://news.medxy.ai/ja/bimodal-swallow-rehabilitation-2/Medxy AIja2026-10-30T02:25:03-07:00脳卒中後の嚥下リハビリテーションにおけるデュアルモーダル・バイオフィードバックの活用：声門上嚥下動作の改善効果 https://news.medxy.ai/vi/enhanced-post-stroke-swallowing-recovery/Medxy AIvi2026-10-30T02:24:36-07:00Nâng cao phục hồi nuốt khó sau đột quỵ: Tác động của phản hồi sinh học hai mô thức đối với động tác nuốt trên thanh môn https://news.medxy.ai/enhancing-post-stroke-dysphagia-rehabilitation-impact-of-bimodal-signal-biofeedback-on-the-supraglottic-swallowing-maneuver/Medxy AIen2026-10-30T02:24:14-07:00Enhancing Post-Stroke Dysphagia Rehabilitation: Impact of Bimodal Signal Biofeedback on the Supraglottic Swallowing Maneuver https://news.medxy.ai/zh/salivary-extracellular-vesicles-2/Medxy AIzh2026-10-30T02:23:33-07:00非手术牙周治疗后唾液细胞外囊泡的动态变化：洞察牙周炎治疗反应的新窗口 https://news.medxy.ai/ja/dynamic-salivary-extracellular-vesicles/Medxy AIja2026-10-30T02:23:12-07:00歯周治療後の唾液細胞外小胞のダイナミックな変化――歯周炎治療反応を映す新たな窓 https://news.medxy.ai/vi/salivary-extracellular-vesicles/Medxy AIvi2026-10-30T02:22:47-07:00Biến đổi động của túi ngoại bào trong nước bọt sau điều trị nha chu không phẫu thuật: Một cửa sổ mới để đánh giá đáp ứng điều trị viêm nha chu https://news.medxy.ai/dynamic-changes-in-salivary-extracellular-vesicles-post-non-surgical-periodontal-therapy-a-novel-window-into-periodontitis-treatment-response/Medxy AIen2026-10-30T02:22:27-07:00Dynamic Changes in Salivary Extracellular Vesicles Post Non-Surgical Periodontal Therapy: A Novel Window into Periodontitis Treatment Response https://news.medxy.ai/zh/ravulizumab-iga-nephropathy-trial/Medxy AIzh2026-10-30T02:21:52-07:00Ravulizumab用于IgA肾病：3期试验中期分析与转化研究启示 https://news.medxy.ai/ja/ravulizumab-iga-nephropathy/Medxy AIja2026-10-30T02:21:28-07:00IgA腎症におけるラブリズマブ：第3相試験中間解析とトランスレーショナル・インサイト https://news.medxy.ai/vi/ravulizumab-iga-nephropathy-interim-analysis/Medxy AIvi2026-10-30T02:20:59-07:00Ravulizumab trong bệnh thận IgA: Phân tích trung gian thử nghiệm pha 3 và những hiểu biết chuyển dịch https://news.medxy.ai/ravulizumab-in-iga-nephropathy-interim-phase-3-trial-analysis-and-translational-insights/Medxy AIen2026-10-30T02:20:35-07:00Ravulizumab in IgA Nephropathy: Interim Phase 3 Trial Analysis and Translational Insights